Breaking news, curated around the clock
Home /Science

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Science | 2026-08-19 at 16:53 UTC | Source: arstechnica.com
The vaccine reportedly thwarted the cancer's return and spread.
Read Full Article →
← More Science news
Related Articles
2026-08-19 · 13:33
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
2026-08-19 · 16:54
Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8…
2026-08-19 · 15:00
Supercentenarians have hypervigilant immune systems that fight off cancer
People aged 110 or older seem to have a disproportionately high number of immune cells that fight off cancer…
2026-08-19 · 16:30
Lindsay Clancy's trial puts postpartum psychosis on the map
Postpartum psychosis is a psychiatric emergency that can involve mania, depression, hallucinations and…
2026-08-18 · 09:00
Planes flying over the Atlantic will be re-routed to avoid contrails
Operation Blue Skies is the world’s first trial to deploy contrail avoidance measures across an entire…